Sunovion's Aptiom eslicarbazepine acetate Receives FDA Approval for Expanded Indication to Treat Partial-Onset Seizures in Children and Adolescents...

  • Steven Wolf

Press/Media

Period25 Sep 2017

Media coverage

1

Media coverage

  • TitleSunovion's Aptiom eslicarbazepine acetate Receives FDA Approval for Expanded Indication to Treat Partial-Onset Seizures in Children and Adolescents...
    Media name/outletPharmacy Choice
    Country/TerritoryUnited States
    Date25/09/17
    URLwww.pharmacychoice.com/News/article.cfm?Article_ID=1846482
    PersonsSteven Wolf